FILE:CVH/CVH-8K-20070112125404.txt.gz
EVENTS:	Triggering Events That Accelerate or Increase a Direct Financial Obligation under an Off-Balance Sheet Arrangement	Financial Statements and Exhibits
TEXT:
ITEM: Triggering Events That Accelerate or Increase a Direct Financial Obligation under an Off-Balance Sheet Arrangement
ITEM: Financial Statements and Exhibits
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
 
FORM 8-K
CURRENT REPORT
 
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
 
Date of report (Date of earliest event reported)
January 12, 2007
 
 
COVENTRY HEALTH CARE, INC.
(Exact name of registrant as specified in its charter).
 
 
 
6705 Rockledge Drive, Suite 900, Bethesda, Maryland 20817
(Address of principal executive offices) (Zip Code)
 
(301) 581-0600
(Registrant's telephone number, including area code)
 
Not Applicable
(Former name or former address, if changed since last report)
 
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):
 
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
o
 
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
o
 
Precommencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
o
 
Precommencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
o
SECTION 2  FINANCIAL INFORMATION
 
ITEM 2.04  Triggering Events That Accelerate or Increase a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement.
 
On January 12, 2007, Coventry Health Care, Inc. (the "Company") issued a news release announcing that it will redeem all $170.5 million of its outstanding 8.125% Senior Notes on February 15, 2007. In accordance with the terms of the indenture dated February 1, 2002, the Company sent an irrevocable notice of redemption to all registered holders on January 12, 2007. The Company will redeem the Senior Notes at a redemption price equal to 104.063% of the principal amount plus any interest accrued and unpaid to the redemption date. The CUSIP number for these notes is 222862AB0. A copy of the news release is furnished herewith as Exhibit 99.1. The exhibit is not deemed to be filed for purposes of Section 18 of the Securities Exchange Act of 1934 or incorporated by reference in the Company's filings under the Securities Exchange Act of 1933.
 
SECTION 9  FINANCIAL STATEMENT AND EXHIBITS
 
ITEM 9.01  Financial Statements and Exhibits
 
 
 
 
Signature
 
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
 
 
 
 
Exhibit Index
 
 
 
 
 

Exhibit 99.1
6705 Rockledge Drive, Suite 900
Bethesda, MD 20817-1850
(301) 581-0600
 
Chief Financial Officer
(301) 581-5701
 
Drew Asher
Vice President, Investor Relations
(301) 581-5717
 
COVENTRY HEALTH CARE ANNOUNCES
INTENT TO REDEEM OUTSTANDING SENIOR NOTES
 
Bethesda, Maryland (January 12, 2007)  Coventry Health Care, Inc. (NYSE: CVH) announced today that it will redeem all $170.5 million of its outstanding 8.125% Senior Notes on February 15, 2007. Coventry will redeem the Senior Notes at a redemption price equal to 104.063% of the principal amount plus any interest accrued and unpaid to the redemption date. The CUSIP number for these notes is 222862AB0. A notice of redemption will be sent by U.S. Bank National Association, the Trustee for the Senior Notes, to all registered holders.
 
Coventry will record a charge, including the write-off of previously paid unamortized issuance costs, of approximately $9.1 million before tax, or $0.04 per diluted share in the first quarter of 2007. Coventry anticipates the funds for payment of the redemption price will be provided by available cash, draws under its bank credit facility, or issuance of new debt securities. Inclusive of this charge, Coventry is maintaining previously provided 2007 diluted earnings per share guidance in the range of $3.82 - $3.95.
 
This press release contains forward-looking statements made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Forward-looking statements are defined as statements that are not historical facts and include those statements relating to future events or future financial performance. Actual performance may be significantly impacted by certain risks and uncertainties, including those described in Coventry's Annual Report on Form 10-K for the year ended December 31, 2005 and Coventry's Form 10-Q for the quarter ended September 30, 2006. Coventry undertakes an obligation to update or revise any forward-looking statements.
 
Coventry Health Care is a national managed health care company based in Bethesda, Maryland operating health plans, insurance companies, network rental, managed care and workers' compensation services companies. Coventry provides a full range of risk and fee-based managed care products and services, including HMO, PPO, POS, Medicare Advantage, Medicare Prescription Drug Plans, Medicaid, Workers' Compensation services and Network Rental to a broad cross section of individuals, employer and government-funded groups, government agencies, and other insurance carriers and administrators in all 50 states as well as the District of Columbia and Puerto Rico. More information is available on the Internet at www.cvty.com.
 
 
 
 


